BNR (Burning Rock Biotech Limited American Depositary Shares) Stock Analysis - Politician Trades

Burning Rock Biotech Limited American Depositary Shares (BNR) is a publicly traded Healthcare sector company. As of May 21, 2026, BNR trades at $17.25 with a market cap of $176.12M and a P/E ratio of 0.00. BNR moved +0.00% today. Year to date, BNR is -31.78%; over the trailing twelve months it is +473.88%. Its 52-week range spans $2.18 to $41.72. Rallies surfaces BNR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded BNR stock?

Rallies tracks politician and congressional stock disclosures for BNR, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

BNR Key Metrics

Key financial metrics for BNR
MetricValue
Price$17.25
Market Cap$176.12M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$41.72
52-Week Low$2.18
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest BNR News

Recent BNR Insider Trades

  • Han Yusheng bought 314.87K (~$5.47M) on Mar 31, 2026.

BNR Analyst Consensus

BNR analyst coverage data. Average price target: $0.00.

Common questions about BNR

Which politicians traded BNR stock?
Rallies tracks politician and congressional stock disclosures for BNR, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in BNR?
Yes. Rallies tracks politician and congressional stock disclosures for BNR, including reported purchases, sales, dates, owners, and trade amounts when available.
Is BNR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BNR. It does not provide personalized investment advice.
BNR

BNR